Welcome to Coulter Partners Global (English)

17 July 2023

Top hires for VC & PE portfolio companies Q2-2023

Search Highlights

Recent top global hires for Venture Capital and Private Equity portfolio companies, covering a broad range of disciplines and sectors across Life Sciences, Health and Tech.

This quarter’s successful placements include:

Function Focus area Location
CEO Cell therapy Switzerland
CEO Contract research services Australia
CEO Vaccines Switzerland
Chief Technology Officer Medical information services UK
Chief Scientific Officer Small molecule biopharma Denmark
Global Head of Marketing Natural ingredients Denmark
VP Cancer Biology tRNA-based therapeutics US
VP Regulatory & Quality Affairs Ophthalmology technology France
VP Business Development Oncology Novel drug discovery US
VP Corporate Development Radiopharmaceuticals Germany/ China
Country Chief Financial Officer Veterinary services Austria
Chair AI/Machine learning for drug discovery Eastern Europe
Board Director Cell therapy Switzerland
Partner Life science investor UK

Newly opened projects include:

Function Focus area Location
CEO Medtech France
CEO GPCR immunotherapies US
Chief Business Officer Precision biotherapeutics Singapore
Chief Technology Officer Foodtech Belgium
Chief Medical Officer siRNA technology US
Chief Hospital Officer EHR data platform Spain
Chief Development Officer Cancer immunotherapies Germany
VP Generative AI Drug discovery UK
VP Clinical and Regulatory Implantable devices UK
VP Business Development Contract research services US
Head Pharma Clinical Development Drug delivery US
Board Director T-cell therapies Sweden
Board Director Digitalised nutrition / wellness Switzerland
Scientific Operating Partner Science-focused VC UK


A new version of Coulter Partners is available.